401 Avsnitt

  1. Episode 123: Maha Hussain - The Uromigos Legends in GU Cancer series

    Publicerades: 2021-08-20

  2. Episode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer series

    Publicerades: 2021-08-16

  3. Episode 121: Conflicts of Interest with the podcasts

    Publicerades: 2021-08-04

  4. Episode 119: EAU - Surgery in urothelial cancer

    Publicerades: 2021-07-23

  5. Episode 118: Prostate cancer highlights at EAU

    Publicerades: 2021-07-20

  6. Episode 117: PD1/VEGF adverse event management in renal cancer

    Publicerades: 2021-07-20

  7. Episode 116: Renal cancer surgery controversies at EAU

    Publicerades: 2021-07-14

  8. Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population

    Publicerades: 2021-07-05

  9. Episode 115: Triplet therapy for 1st line metastatic prostate cancer

    Publicerades: 2021-07-01

  10. Episode 114: Radionucleotides in prostate cancer

    Publicerades: 2021-06-18

  11. Episode 113: ASCO 2021 Enazlutamide +/- Radium-223

    Publicerades: 2021-06-18

  12. Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer

    Publicerades: 2021-06-08

  13. Episode 110: PEACE1 - Triplet therapy in prostate cancer

    Publicerades: 2021-06-08

  14. Episode 109: Adjuvant pembrolizumab in renal cancer

    Publicerades: 2021-06-07

  15. Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer

    Publicerades: 2021-06-07

  16. Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing

    Publicerades: 2021-06-07

  17. Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021

    Publicerades: 2021-06-07

  18. Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer

    Publicerades: 2021-06-07

  19. Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer

    Publicerades: 2021-06-06

  20. Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer

    Publicerades: 2021-06-06

15 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site